Drug Law

National Cancer Institute Removes Pro-Marijuana Reference

| by NORML

By Russ Belville

You may recall last Wednesday when we pointed out this incredible paragraph on the website of the National Cancer Institute at cancer.gov, on their general information about medical cannabis, touting its antitumoral effects:

Popular Video

People were so furious about this Pepsi ad that Pepsi pulled it after just one day. Watch it here and decide if it's offensive:

The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice of integrative oncology, the health care provider may recommend medicinal Cannabis not only for symptom management but also for its possible direct antitumor effect.

NCI apparently got a talking to from someone, because now that page has been scrubbed of any reference to the direct antitumoral effects of cannabis:

Popular Video

People were so furious about this Pepsi ad that Pepsi pulled it after just one day. Watch it here and decide if it's offensive:

The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. Though no relevant surveys of practice patterns exist, it appears that physicians caring for cancer patients who prescribe medicinal Cannabis predominantly do so for symptom management.

See for yourself:

Click the image for the full-size screenshots of the NCI's Cancer.gov website